David Yonick, MD
Plastic and Reconstructive Surgery · Saint Louis, MONPI 1568626752
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $550 of the $700 with a category attached, or 78.6%. 9 manufacturers reported payments, led by AbbVie at 31.3% of the total. Reporting peaked in 2020 at $208 and has fallen 53.2% since, to $97 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in MO, where the typical reported total is $3,093.
Across 29 payments — averaging $24.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$219
- Galderma Laboratories, L.p.$150
- Mentor Worldwide LLC$96
- Sientra, Inc.$73
- RTI Surgical, Inc$61
- Johnson & Johnson$40
- plus $61 from 3 others
What the payments were for
- Speaking & faculty fees$15021%
- Food & beverage$55079%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $219 |
| Galderma Laboratories, L.p. | 1 | $150 |
| Mentor Worldwide LLC | 5 | $96 |
| Sientra, Inc. | 3 | $73 |
| RTI Surgical, Inc | 2 | $61 |
| Johnson & Johnson | 1 | $40 |
| Solventum Corporation | 1 | $24 |
| Tepha Inc | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
How this compares
$700 in reported general payments places this provider in the 25th percentile of 61 plastic and reconstructive surgery providers in Missouri.
See all plastic and reconstructive surgery providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $90 |
| Ondansetron Hcl | 19 | $75 |
| Ibuprofen | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Saint Louis
- Terence MyckatynSaint Louis$399K
- David CaplinSaint Louis$81K
- Patricia McGuireSaint Louis$66K
- Mitchell PetSaint Louis$42K
- Kamlesh PatelSaint Louis$41K
- John HoldsSaint Louis$40K
- Marissa Morningstar TenenbaumSaint Louis$28K
- Charles NathanSaint Louis$19K
- Brock RidenourSaint Louis$9K
- Milind KachareSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.